Navigation Links
Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
Date:6/2/2008

ly ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon(TM) in Alzheimer's disease, a Phase 2 clinical trial of Dimebon in patients with Huntington's disease, and a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer. For more information, please visit us at http://www.medivation.com.

This press release contains forward-looking statements, including statements regarding anticipated clinical and regulatory milestones, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ significantly from those projected. You are cautioned not to place undue reliance on the forward- looking statements, which speak only as of the date of this release. None of the Company's product candidates has been approved for sale, significant additional animal and human testing is required in order to seek marketing approval for any of its product candidates, and Medivation cannot assure you that marketing approval can be obtained for any of its product candidates. Furthermore, as is typically the case at this stage of the regulatory review process, the FDA has not yet performed an in-depth review of Medivation's preclinical and clinical data, so its views remain subject to change. Medivation's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2007 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, include information about additional factors that could affect the Company's financial and operating results.


'/>"/>
SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
2. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
3. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
4. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
5. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
7. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
8. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
9. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
10. Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer
11. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Connected health infrastructure is emerging as ... aiding diagnosis, monitoring and prevention in the healthcare ... stakeholders must first ensure that interoperability and connectivity ... http://photos.prnewswire.com/prnh/20150526/218313LOGO New analysis ... Connectivity and Interoperability, finds that the adoption of ...
(Date:5/26/2015)... 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: IN; ... a provisional patent application with the United States ... treatment of Epidermolysis Bullosa Simplex (EBS) using novel ... Dr. Sazzad Hossain , ... excited to file our first patent covering the ...
(Date:5/22/2015)... May 22, 2015  Research and Benchmarking firm, ... Medical Affairs Roundtable on Thursday, May ... virtual roundtable to discuss "Medical Affairs, Role in ... Practices, Medical Affairs Consortium provides Medical Affairs leaders ... key challenges they face. The consortium has developed ...
Breaking Medicine Technology:Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 2Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 3InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 2InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 3Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2
(Date:5/26/2015)... Pass, OR (PRWEB) May 26, 2015 ... always fatal if not caught early. Melanoma is also ... water advocate Sharon Kleyne, the melanoma rate is on ... radiation. While the melanoma risk for indoor tanning salon ... these establishments. The most recent ban, in Pennsylvania, coincides ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Learning ZoneXpress ... line, Nutrition Education Cards . These cards have ... engaging photography and simple, easy-to-read text, these new educational ... . They offer practical nutrition tips and suggestions to ... titles available are: , + MyPlate: Eat for a ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 General ... with MarkLogic Corporation. The alliance ensures joint customers ... platform and General Networks’ expertise in building enterprise ... and MarkLogic will help customers integrate, manage and ... and business processes. , “Our customers are seeking ...
(Date:5/26/2015)... 26, 2015 Javon Bea President ... responsible for using her quality improvement and organizational development ... Denise also provides leadership and direction for the financial, ... Mercy Home Health Care and Mercy Durable Medical Equipment. ... care administration with the last 20 in home care ...
(Date:5/26/2015)... Boston, MA. (PRWEB) May 26, 2015 ... Standing option in their online Master of Social ... Program sites and on the Charles River Campus, the ... , This Advanced Standing option is open ... by the Council on Social Work Education. Students entering ...
Breaking Medicine News(10 mins):Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 3Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 3
... an interesting manifestation of post traumatic stress disorder (PTSD) - ... frequented chat rooms while at work, his employers, the ... the 58-year old James Pacenza is suing them for $ ... IBM should have offered him sympathy and treatment instead of ...
... report [Thursday, 24 May 2007] the BMA says it is extremely ... in law enforcement situations, in the belief that these can ... produced by the BMAs Board of Science, concludes that it is ... the right individuals in a way that is both effective and ...
... In a move to improve global public health, Weill ... heart disease drug onto the World Health Organization's ... guideline for developing countries to choose which high-priority drugs ... ,Students from Weill Cornell's chapter of Universities Allied for ...
... shown that too much heat can decrease sperm count, and retard ... Bourn Hall Clinic in Cambridgeshire have suggested that soaking up the ... fathering a child. ,Many couples believe that a foreign ... up fully. ,However, sperm takes eight weeks to ...
... Field was diagnosed with osteoporosis in 2005, it was a ... had always exercised, and I had always taken calcium,' Field ... a good girl all the way down the line, but ... in town to talk to legislators at a Capitol Hill ...
... of cancer they say will aid the search for cancer-causing ... ,The study was conducted by a team ... at the Dana-Farber Cancer Institute. ,Conventional mouse models ... embryo. , "You plug it into the mouse, ...
Cached Medicine News:Health News:Sacked Employee Says Stress Led to His Sex Addiction 2Health News:Using Drugs as Weapons can Never Be 'non Lethal', Say Doctors 2Health News:Medical College Students Help Change Global Health Policy 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 3Health News:New Mouse Model to Aid in Cancer-causing Genes Hunt 2
HYDRACLEAR is our brandname for a remarkable moisture rich element that lies throughout the interior and exterior of the ACUVUE ADVANCE Brand Contact Lenses creating a unique soft, silky feel....
... For use in the percutaneous retrieval of ... or wire guides, and other foreign objects. ... snare around the lead body. It is delivered ... long, flexible 12 Fr cannula that is placed ...
... existing patented technologies such as Simtec ... with the new innovations of automated ... determination, and intelligent collision avoidance in ... treatment delivery with enhanced patient safety. ...
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come standard with the latest high-precision dose sculpting technology for advanced tumor control....
Medicine Products: